- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05883215
Effects of Social Media Usage on Pain Catastrophizing and Disease Impact in Female Patients With Fibromyalgia Syndrome
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Mustafa H Temel, M.D.
- Phone Number: +905342714872
- Email: mhuseyintemel@gmail.com
Study Contact Backup
- Name: Fatih Bağcıer, M.D.
- Phone Number: 05442429042
- Email: bagcier_42@hotmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Giving consent.
- Being diagnosed with Fibromyalgia syndrome
- Being female
Exclusion Criteria:
- Not giving consent.
- Any disability or illness that may prevent filling out the form or communicating.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Female Patients Diagnosed with Fibromyalgia Syndrome
Female patients who give consent to participate and are diagnosed with fibromyalgia syndrome.
|
The pain catastrophizing scale is a self-report questionnaire used to assess an individual's tendency to engage in catastrophic thinking when experiencing pain.
It measures the extent to which a person magnifies, feels helpless, and feels unable to cope with pain.
The scale typically consists of several items that ask individuals to rate the degree to which they experience specific thoughts or emotions related to pain catastrophizing, such as "I worry all the time about whether the pain will end" or "I feel like I can't stand it anymore."
Participants provide responses on a Likert scale indicating the intensity or frequency of their agreement with each statement.
The scale helps researchers and healthcare professionals gain insights into an individual's cognitive and emotional responses to pain, which can have implications for pain management strategies and overall well-being.
Beck Anxiety Inventory" (BAI), which is designed to measure the severity of anxiety symptoms in individuals.
The BAI is a self-report questionnaire consisting of 21 items that assess various symptoms of anxiety, such as nervousness, fear, and physiological manifestations of anxiety.
Participants rate the intensity of their symptoms over the past week on a scale ranging from 0 (not at all) to 3 (severely).
The scores obtained on the BAI can help clinicians and researchers evaluate the presence and severity of anxiety symptoms, monitor changes over time, and guide treatment decisions.
It is important to note that the BAI is not a diagnostic tool but rather a measure of self-reported anxiety symptoms.
The Social Media Use Integration Scale (SMUIS) is a self-report measure that assesses the degree to which individuals integrate social media into their daily lives.
It aims to capture the extent to which individuals incorporate social media use into various aspects of their routines, behaviors, and identity.
The scale typically consists of items that assess factors such as the frequency and duration of social media use, the importance and impact of social media on personal relationships, the integration of social media into daily activities, and the emotional connection to social media.
The Fibromyalgia Impact Questionnaire (FIQ) is a widely used self-report measure specifically designed to assess the impact of fibromyalgia on various aspects of a person's life. It is a multidimensional questionnaire that evaluates the physical functioning, social functioning, and overall well-being of individuals with fibromyalgia. The FIQ typically consists of items that ask individuals to rate the impact of fibromyalgia on their ability to perform daily activities, such as work, household chores, and recreational activities. It also assesses the severity of fibromyalgia symptoms, including pain, fatigue, sleep disturbances, and cognitive difficulties. Additionally, the questionnaire may include items related to emotional well-being, social support, and overall quality of life. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation between social media use and pain catastrophizing
Time Frame: 1 day
|
The possible correlation between the results obtained with the social media integration scale and the results obtained with the pain catastrophizing scale will be investigated with statistical methods.
|
1 day
|
Correlation between social media use and disease impact
Time Frame: 1 day
|
The possible correlation between the results obtained with the social media integration scale and the results obtained with the fibromyalgia impact questionnaire will be investigated with statistical methods.
|
1 day
|
Correlation between social media use and anxiety
Time Frame: 1 day
|
The possible correlation between the results obtained with the social media integration scale and the results obtained with the Beck Anxiety Inventory will be investigated with statistical methods.
|
1 day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mustafa H Temel, M.D., Uskudar State Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMS1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
University of AberdeenCompletedFibromyalgia | Fibromyalgia, Primary | Fibromyalgia, SecondaryUnited Kingdom
-
Eli Lilly and CompanyCompletedFibromyalgia, Primary | Fibromyalgia, SecondaryMexico
-
Rasmia ElgoharyNot yet recruiting
-
Spaulding Rehabilitation HospitalNot yet recruiting
-
Cairo UniversityNot yet recruiting
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
University of UtahTerminated
-
State University of New York - Upstate Medical...CompletedFibromyalgia, PrimaryUnited States
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Tel-Aviv Sourasky Medical CenterCompletedFibromyalgia (FM)Israel
Clinical Trials on Pain catastrophizing scale
-
Acibadem UniversityNot yet recruitingNeck Pain | Kinesiophobia | Fear of MovementTurkey
-
Konya Beyhekim Training and Research HospitalRecruiting
-
Aalborg UniversitySpine Centre of Southern DenmarkCompletedChronic Low Back Pain | Catastrophizing Pain | Pain, SomaticDenmark
-
B.P. Koirala Institute of Health SciencesCompleted
-
Konya Beyhekim Training and Research HospitalNot yet recruiting
-
Samsun UniversityRecruitingPain CatastrophizingTurkey
-
Konya Beyhekim Training and Research HospitalNot yet recruiting
-
Kutahya Health Sciences UniversityCompletedChronic Pain | Juvenile Idiopathic ArthritisTurkey
-
Mclean HospitalNational Institute on Drug Abuse (NIDA)Recruiting